लोड हो रहा है...

Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa

BACKGROUND: Methods to improve the clinical efficacy of currently available antibiotics against multidrug resistant bacteria in cystic fibrosis (CF) chronic rhinosinusitis (CRS) are greatly needed. Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, was recently identified...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Am J Rhinol Allergy
मुख्य लेखकों: Cho, Do-Yeon, Lim, Dong Jin, Mackey, Calvin, Skinner, Daniel, Zhang, Shaoyan, McCormick, Justin, Woodworth, Bradford A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publications 2018
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728449/
https://ncbi.nlm.nih.gov/pubmed/30585080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1945892418815615
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!